# A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

> **NCT04253015** · — · RECRUITING · sponsor: **RECORDATI GROUP** · enrollment: 125 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **OTHER:** Data-collection

## Key facts

- **NCT ID:** NCT04253015
- **Lead sponsor:** RECORDATI GROUP
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-30
- **Primary completion:** 2032-03-31
- **Final completion:** 2032-06-15
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2024-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04253015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04253015, "A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04253015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*